ArriVent BioPharma, Inc.
AVBP
$29.79
-$0.49-1.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.32% | 4.33% | 4.18% | 27.40% | 33.85% |
| Total Receivables | -- | -- | -- | 0.00% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.83% | 669.89% | -66.30% | -29.86% | -35.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.70% | 5.02% | -0.03% | 51.06% | 65.08% |
| Total Current Assets | 13.04% | 4.75% | 3.64% | 28.41% | 34.64% |
|
|
|||||
| Total Current Assets | 13.04% | 4.75% | 3.64% | 28.41% | 34.64% |
| Net Property, Plant & Equipment | 0.00% | 2,746.15% | -73.47% | -42.35% | -29.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.22% | -13.13% | 43.89% | -62.42% | 172.16% |
| Total Assets | 13.00% | 4.84% | 2.03% | 21.17% | 25.06% |
|
|
|||||
| Total Accounts Payable | -74.60% | 47.07% | 0.02% | 46.13% | -6.97% |
| Total Accrued Expenses | 56.53% | -19.14% | 28.44% | 0.59% | 83.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 221.21% | 607.14% | -75.00% | -42.86% | -28.99% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.40% | -3.66% | 20.35% | 9.79% | 51.59% |
|
|
|||||
| Total Current Liabilities | 11.40% | -3.66% | 20.35% | 9.79% | 51.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -89.69% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.12% | -2.43% | 20.35% | 9.79% | 51.59% |
|
|
|||||
| Common Stock & APIC | 12.01% | 8.48% | 5.63% | 15.39% | 15.58% |
| Retained Earnings | -11.14% | -10.71% | -9.63% | -10.47% | -10.37% |
| Treasury Stock & Other | 1.11% | -2,028.57% | -93.20% | 1,244.44% | -5.88% |
| Total Common Equity | 13.23% | 5.45% | 0.73% | 22.06% | 23.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.23% | 5.45% | 0.73% | 22.06% | 23.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.23% | 5.45% | 0.73% | 22.06% | 23.37% |
|
|
|||||